OBJECTIVE： To summarize the role of clinical pharmacists on the prevention of medicine-induced epilepsy and common epilepsy-inducing drugs in clinic. METHODS： The role of clinical pharmacists in whole process of pharmaceutical care for an epilepsy patient was introduced， and clinical pharmacists assisted physicians to reduce the risk of drug-induced epilepsy. The role of clinical pharmacists on the prevention of epilepsy-inducing medicine during pharmaceutical care was explored through reviewing literature， summarizing epilepsy-inducing drug and analyzing mechanism. RESULTS： The role of clinical pharmacists in diagnosis and treatment of epilepsy included that analyzing the risk of medicine-induced epilepsy by inquiring about the history of drug use， guiding patients to gradually stop taking risk drugs， participating in the formulation of clinical medication plan and drug risk during diagnosis and treatment， assisting physicians to adjust medication plan， monitoring the change of patient’s symptoms after drug， “special medication notification for epilepsy patient”， etc. The types of common epilepsy-inducing medicine included antibiotics （fluoroquinolone， β-lactam， etc.）， drugs for central nervous system （sedative and antiepileptic drug， mental disorders drug， etc.）， Chinese herbal drug， Chinese patent drug， antipyretic- analgesic and anti-inflammatory drug， circulatory system drug and other drugs. The mechanisms of drug effect included entering the brain through the blood cerebrospinal fluid barrier， inhibiting the binding of γ-aminobutyric acid to the receptor site， producing amino or free radicals and affecting a part of the cerebral cortex. CONCLUSIONS： Clinical pharmacists play an irreplaceable role in the safety of drug use in epilepsy patient. Their focuses to epilepsy-inducing drug are of significance to clinical practice.